Search / Trial NCT06614426

Surgical Treatment of Peri-implantitis Defects

Launched by ABEER HAKAM · Sep 25, 2024

Trial Information

Current as of December 21, 2024

Not yet recruiting

Keywords

ClinConnect Summary

Research design

* Prospective, in which participants will be recruited and then followed up throughout a specified period of time.
* Randomized, parallel designed, concurrent controlled trial with participants randomly allocated to either control or test groups.
* Single-blinded as the outcome accessors will be blinded to the intervention.

Materials and Methods:

Patients attending Dubai Dental Hospital and requiring treatment of peri-implantitis will be invited to take part in this randomized controlled trial based on the following inclusion and exclusion criteria:

Inclusion criteria:

...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged 18 or over.
  • Require treatment of peri-implantitis (defined as the presence of bleeding and/or suppuration on gentle probing, probing depths of ≥ 6 mm, presence of bone loss beyond crestal bone level changes resulting from initial bone remodeling).
  • Screw retained implant crown.
  • Good compliance and commitment to attend follow-up review appointments.
  • Willing to provide informed consent.
  • Exclusion Criteria:
  • History of surgical therapy of peri-implantitis.
  • Peri-implant defects indicated for regenerative procedure (i.e. contained bony defect).
  • Cement retained implant crown.
  • Systemic/local antibiotics during the previous 6 months.
  • Bone metabolic disease and/or taking medications that affect bone metabolism.
  • History of malignancy, radiotherapy or chemotherapy.
  • Pregnant or lactating women.
  • Smokers

About Abeer Hakam

Abeer Hakam is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapies. With a focus on precision medicine, Abeer Hakam collaborates with leading research institutions and healthcare professionals to design and implement rigorous clinical trials. The organization prioritizes ethical standards, patient safety, and regulatory compliance, ensuring that all studies adhere to the highest scientific and ethical guidelines. By fostering collaboration and leveraging cutting-edge technologies, Abeer Hakam aims to accelerate the development of transformative treatments and contribute to the global healthcare landscape.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0